Efficacy of cabozantinib (cabo) vs everolimus (eve) by metastatic site and tumor burden in patients (pts) with advanced renal cell carcinoma (RCC) in the phase 3 METEOR trial

T. B. Powles, B. Escudier, P. de Souza, S. Chowdhury, D. Pook, U. Harmenberg, N. Basappa, D. Geynisman, J. Merchan, B. G. Redman, C. Ryan, O. Goodman, T. Ho, P. Singh, J. Lougheed, M. Patel, J. J. Knox, R. J. Motzer, T. K. Choueiri

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number814P
Number of pages1
JournalAnnals of Oncology
Issue numberS6
Publication statusPublished - 1 Oct 2016
Externally publishedYes

Cite this